GO:0090318 regulation of chylomicron remodeling: Lipid Absorption Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090318 describes any process that modulates the rate, frequency, or extent of chylomicron remodeling, the acquisition, loss, or modification of protein or lipid within a chylomicron, including triglyceride hydrolysis by lipoprotein lipase and subsequent free fatty acid loss.
• Chylomicron remodeling is central to intestinal lipid absorption and systemic triglyceride clearance, and chylomicrons themselves regulate lacteal permeability and lymphatic lipid transport.
• Key proteins include CD36, lipoprotein lipase, apolipoproteins, and lymphatic endothelial regulators that govern chylomicron processing and trafficking.
• Dysregulation of chylomicron remodeling contributes to hypertriglyceridemia, metabolic disease, and altered intestinal lipid handling, with genetic and lifestyle factors shaping risk.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate regulators in intestinal and hepatic lipid metabolism.
• Organ-specific lymphatic and liver cell cooperation provides the physiological context for chylomicron remodeling studies.
Description
Chylomicrons are large triglyceride-rich lipoproteins assembled in the intestine that transport dietary lipids through lymph and blood. The biological process GO:0090318, regulation of chylomicron remodeling, encompasses any mechanism that modulates the acquisition, loss, or modification of proteins and lipids within a chylomicron, including hydrolysis of triglyceride by lipoprotein lipase and the subsequent loss of free fatty acid. Because chylomicron remodeling directly affects lipid absorption and clearance, understanding its regulation is essential for researchers studying metabolic physiology and disease. Recent work has shown that chylomicrons are not passive cargo but active regulators of lacteal permeability and intestinal lipid absorption, making their remodeling a dynamic and physiologically significant process. Intestinal CD36 and other lipid utilization proteins coordinate fatty acid uptake and chylomicron assembly, linking remodeling to gut homeostasis. At the systemic level, genetic and lifestyle factors influence hypertriglyceridemia, underscoring the translational relevance of chylomicron regulation. This article integrates the QuickGO definition with verified literature to outline the mechanisms, key genes, disease links, and research methods relevant to GO:0090318.
regulation of chylomicron remodeling At A Glance
| GO ID | GO:0090318 |
|---|---|
| GO term | regulation of chylomicron remodeling |
| Ontology | biological_process |
| Synonym | regulation of chylomicron remodelling |
| Major function | Modulates the rate, frequency, or extent of chylomicron remodeling, including triglyceride hydrolysis by lipoprotein lipase and free fatty acid loss |
| Related process | Chylomicron remodeling |
| Biological context | Intestinal lipid absorption, lymphatic transport, and systemic triglyceride clearance |
| Key regulators | Lipoprotein lipase, CD36, apolipoproteins, and lymphatic endothelial factors |
| Disease relevance | Hypertriglyceridemia and metabolic disorders linked to impaired lipid handling |
What Is GO:0090318?
GO:0090318, regulation of chylomicron remodeling, is defined as any process that modulates the rate, frequency, or extent of chylomicron remodeling. Chylomicron remodeling itself is the acquisition, loss, or modification of a protein or lipid within a chylomicron, including the hydrolysis of triglyceride by lipoprotein lipase and the subsequent loss of free fatty acid. In practical terms, this GO term captures the regulatory inputs that control how chylomicron composition and size change during lipid transport, rather than the remodeling reaction itself.
Why Is regulation of chylomicron remodeling Important in Cell Biology?
Regulation of chylomicron remodeling is important because it determines how efficiently dietary lipids are absorbed, transported through lymphatics, and cleared from circulation. Chylomicrons regulate lacteal permeability and intestinal lipid absorption, so their remodeling directly influences nutrient uptake and lymphatic function. Intestinal CD36 and related proteins are key to lipid utilization and gut homeostasis, linking remodeling regulation to whole-body energy balance. Dysregulation contributes to hypertriglyceridemia, where genetic and lifestyle factors interact to shape risk. Understanding this process therefore supports research into metabolic disease, intestinal physiology, and therapeutic strategies targeting lipid absorption.
• Controls intestinal lipid absorption and lymphatic transport of dietary fats.
• Regulates lacteal permeability and chylomicron trafficking in the gut.
• Involves CD36 and other lipid utilization proteins critical for gut homeostasis.
• Impacts systemic triglyceride clearance and hypertriglyceridemia risk.
• Provides a mechanistic link between diet, genetics, and metabolic disease.
• Relevant to liver cell cooperation in lipid metabolism.
• Influenced by organ-specific lymphatic functions in HDL and lipid trafficking.
• Targetable by dietary and pharmacological interventions in preclinical models.
• Supports development of CRISPR models for causal gene testing.
• Helps explain how inhibiting menin reduces high-fat diet-induced weight gain via intestinal lipid absorption.
What Happens During regulation of chylomicron remodeling?
Chylomicron Assembly and Secretion
In simple terms: The intestine packages dietary fats into chylomicrons and releases them into lymph.
Chylomicron remodeling begins with the assembly of triglyceride-rich particles in enterocytes, a process dependent on lipid uptake proteins such as CD36. These nascent chylomicrons acquire apolipoproteins and enter lymphatic vessels, where their composition can be modified. Chylomicrons regulate lacteal permeability, meaning their presence and remodeling influence how lymphatics absorb and transport lipids. This step sets the stage for subsequent remodeling events in circulation.
Lipoprotein Lipase-Mediated Triglyceride Hydrolysis
In simple terms: An enzyme called lipoprotein lipase cuts triglycerides inside chylomicrons, releasing free fatty acids.
The QuickGO definition explicitly includes hydrolysis of triglyceride by lipoprotein lipase and the subsequent loss of free fatty acid as part of chylomicron remodeling. Regulation of this step determines how quickly chylomicrons are unloaded and converted to remnants. Intestinal CD36 and other key proteins of lipid utilization participate in fatty acid uptake and processing, indirectly influencing the substrate available for lipase action. This hydrolytic step is a central node for regulatory control.
Acquisition and Loss of Apolipoproteins
In simple terms: Chylomicrons gain and lose surface proteins that determine their fate.
Chylomicron remodeling includes the acquisition, loss, or modification of proteins within the particle. Apolipoproteins exchanged during circulation affect receptor recognition and clearance. Organ-specific lymphatics play distinct roles in regulating lipoprotein trafficking and composition, providing a vascular context for these protein exchanges. Regulation of apolipoprotein dynamics therefore modulates the overall remodeling rate.
Lymphatic Transport and Lacteal Permeability
In simple terms: Chylomicrons travel through lymphatic vessels whose permeability they can influence.
Chylomicrons regulate lacteal permeability and intestinal lipid absorption, establishing a feedback relationship between particle remodeling and lymphatic function. Organ-specific lymphatics further regulate lipoprotein trafficking and composition, including HDL, indicating that lymphatic beds are active participants in lipid transport. This step highlights how regulation of chylomicron remodeling extends beyond the particle itself to the surrounding vascular niche.
Systemic Clearance and Metabolic Integration
In simple terms: Remodeled chylomicron remnants are cleared from blood, connecting gut lipid handling to whole-body metabolism.
After triglyceride hydrolysis and apolipoprotein exchange, chylomicron remnants are cleared by the liver, where multiple cell types cooperate in lipid metabolism. Genetic and lifestyle factors influence hypertriglyceridemia, reflecting the integration of chylomicron remodeling with systemic lipid homeostasis. Preclinical dietary modifications can alter skeletal and metabolic health, providing models to study these systemic effects. Thus, regulation of chylomicron remodeling is a bridge between intestinal absorption and whole-body metabolic control.
Key Genes Involved in GO:0090318 regulation of chylomicron remodeling
The following genes and proteins are central to the regulation of chylomicron remodeling, based on their roles in lipid uptake, lipoprotein hydrolysis, lymphatic transport, and metabolic integration.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD36 | Fatty acid uptake and lipid utilization in intestine | Key marker of intestinal lipid absorption and gut homeostasis |
| LPL | Hydrolyzes triglyceride in chylomicrons | Directly named in GO:0090318 definition; central to remodeling |
| APOA4 | Apolipoprotein component of chylomicrons | Modulates chylomicron assembly and secretion |
| APOB | Structural apolipoprotein of chylomicrons | Required for chylomicron formation and transport |
| APOC2 | Activator of lipoprotein lipase | Regulates lipase activity and triglyceride hydrolysis |
| APOE | Mediates remnant clearance | Links chylomicron remodeling to hepatic uptake |
| MEN1 | Menin, involved in intestinal lipid absorption | Inhibiting menin attenuates high-fat diet-induced weight gain |
| VEGFA | Lymphatic and vascular growth factor | Influences lacteal function and chylomicron transport |
| VEGFR3 | Lymphatic endothelial receptor | Regulates lymphatic permeability and lipid trafficking |
| PROX1 | Lymphatic endothelial transcription factor | Controls lymphatic development and function |
| FOXC2 | Lymphatic valve and vessel regulator | Affects lymphatic lipid transport |
| SCARB1 | HDL receptor and lipid uptake | Organ-specific lymphatic roles in lipoprotein trafficking |
| ABCA1 | Cholesterol efflux transporter | Modifies lipoprotein composition in lymph |
| CYP7A1 | Bile acid synthesis enzyme | Liver cell cooperation in lipid metabolism |
| HNF4A | Hepatic transcription factor | Regulates lipid and lipoprotein genes |
| PPARA | Fatty acid oxidation regulator | Integrates lipid metabolism and energy balance |
| INSIG1 | Lipid synthesis regulator | Modulates triglyceride availability for chylomicrons |
How Is regulation of chylomicron remodeling Regulated?
Regulation of chylomicron remodeling is influenced by dietary composition, genetic variants, and lifestyle factors that together shape hypertriglyceridemia risk. Preclinical dietary modifications can alter metabolic and skeletal health, indicating that nutritional inputs modulate lipid handling pathways. Intestinal CD36 and other lipid utilization proteins respond to lipid availability and contribute to gut homeostasis, providing a layer of local regulation. Chylomicrons themselves regulate lacteal permeability, creating a feedback loop where remodeling affects the lymphatic environment that transports them. Organ-specific lymphatics further modulate lipoprotein trafficking and composition, adding vascular control. Liver cell cooperation integrates these signals for systemic clearance. Inhibiting menin attenuates high-fat diet-induced weight gain by limiting intestinal lipid absorption, demonstrating that specific molecular regulators can be targeted to modulate this process.
regulation of chylomicron remodeling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD36 | Intestinal lipid absorption and gut homeostasis | Intestinal epithelial knockout mouse |
| MEN1 | High-fat diet-induced weight gain and lipid absorption | Menin inhibition or knockout mouse |
| LPL | Hypertriglyceridemia and chylomicron clearance | Liver-specific overexpression or knockout |
| APOC2 | Triglyceride hydrolysis defects | Point-mutation knock-in model |
| VEGFR3 | Lymphatic permeability and lipid transport | Endothelial-specific knockout |
Hypertriglyceridemia and Metabolic Disease
Impaired regulation of chylomicron remodeling contributes to hypertriglyceridemia, a condition influenced by both genetic and lifestyle factors. Because chylomicrons carry dietary triglycerides, defects in their remodeling can lead to elevated circulating lipids and metabolic dysfunction. Integrating genetics and lifestyle data helps identify individuals at risk and guide precision nutrition approaches.
Intestinal Lipid Absorption Disorders
Chylomicrons regulate lacteal permeability and intestinal lipid absorption, so disrupted remodeling may affect nutrient uptake and lymphatic function. Intestinal CD36 and other key proteins of lipid utilization are essential for absorption and gut homeostasis, and their dysfunction can impair lipid handling. Inhibiting menin reduces high-fat diet-induced weight gain by limiting intestinal lipid absorption, highlighting a targetable pathway.
Lymphatic and Lipoprotein Trafficking Abnormalities
Organ-specific lymphatics play distinct roles in regulating lipoprotein trafficking and composition, including HDL. When chylomicron remodeling is dysregulated, lymphatic transport of lipoproteins may be altered, contributing to lipid imbalance. Liver cell cooperation is also required for proper clearance, and disruption can exacerbate metabolic disease.
From regulation of chylomicron remodeling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD36 regulate intestinal chylomicron remodeling? | Intestinal epithelial CD36 knockout |
| Does menin inhibition alter lipid absorption? | Menin knockout or pharmacological inhibition |
| What is the role of lipoprotein lipase in remodeling? | LPL overexpression or point-mutation knock-in |
| How do lymphatic signals affect chylomicron transport? | VEGFR3 conditional knockout |
| Does a candidate gene causally affect hypertriglyceridemia? | CRISPR knockout in hepatocyte or enterocyte lines |
| Can apolipoprotein exchange be tracked? | Tagged knock-in of APOA4 or APOB |
How to Study the regulation of chylomicron remodeling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid absorption assay | Intestinal uptake of dietary fats | Testing menin or CD36 regulators |
| Lymphatic permeability imaging | Lacteal permeability changes | Chylomicron effects on lymphatics |
| Lipoprotein composition analysis | Apolipoprotein and lipid content | Organ-specific lymphatic studies |
| Genetic association analysis | Variant-trait links | Hypertriglyceridemia precision nutrition |
| Dietary modification models | Metabolic and skeletal outcomes | Preclinical nutrition studies |
| Liver cell co-culture | Hepatocyte cooperation in lipid clearance | Remnant clearance mechanisms |
| CRISPR knockout screening | Causal gene identification | Candidate regulator validation |
Genetic Association and Precision Nutrition
Integrating genetics and lifestyle data from cohorts such as UK Biobank and KoGES enables identification of variants associated with hypertriglyceridemia and chylomicron remodeling. These approaches help prioritize candidate genes for functional studies and support precision nutrition strategies.
Intestinal Lipid Absorption Assays
Measuring lipid absorption in vivo, for example after high-fat diet challenge, allows assessment of chylomicron remodeling regulators such as menin. Intestinal CD36 function can be evaluated through fatty acid uptake assays and gut homeostasis readouts.
Lymphatic Transport and Permeability Studies
Chylomicrons regulate lacteal permeability, so imaging and permeability assays in lymphatic vessels are valuable for studying remodeling. Organ-specific lymphatic functions can be dissected using tracers and lipoprotein composition analysis.
Liver Cell Cooperation and Clearance Models
Liver cell cooperation in health and disease provides a framework for studying chylomicron remnant clearance. Preclinical dietary modification models can reveal how nutrition alters skeletal and metabolic outcomes relevant to lipid handling.
How CRISPR Can Be Used to Study GO:0090318 regulation of chylomicron remodeling
Knockout
CRISPR knockout of candidate genes such as CD36 or MEN1 enables causal testing of their role in chylomicron remodeling and intestinal lipid absorption. Knockout models can reveal whether a gene is required for normal lipid handling and whether its loss alters hypertriglyceridemia risk.
Point Mutation
Point-mutation models can mimic naturally occurring variants in genes like APOC2 or LPL to study their impact on triglyceride hydrolysis and chylomicron remodeling. Such models help connect genetic findings from cohort studies to functional outcomes.
Knock-in
Knock-in of tagged apolipoproteins or reporters allows tracking of chylomicron composition and trafficking in vivo. This approach supports studies of apolipoprotein exchange and lymphatic transport.
Overexpression
Overexpression of regulators such as lipoprotein lipase or CD36 can test whether increased activity enhances chylomicron remodeling and lipid clearance. These models complement knockout studies and help define directionality of effect.
How EDITGENE Supports regulation of chylomicron remodeling Research
Researchers studying regulation of chylomicron remodeling-related genes often need to determine whether a candidate gene is causally involved in lipid absorption, lipoprotein hydrolysis, or lymphatic transport. EDITGENE provides CRISPR-based cell models and screening services to accelerate this causal validation.
Contact EDITGENE today to design your custom CRISPR model for regulation of chylomicron remodeling research.
Frequently Asked Questions About regulation of chylomicron remodeling
What is GO:0090318 regulation of chylomicron remodeling?
GO:0090318 is a biological process term describing any process that modulates the rate, frequency, or extent of chylomicron remodeling, including triglyceride hydrolysis by lipoprotein lipase and free fatty acid loss.
What is chylomicron remodeling?
Chylomicron remodeling is the acquisition, loss, or modification of a protein or lipid within a chylomicron, including hydrolysis of triglyceride by lipoprotein lipase and subsequent loss of free fatty acid.
What genes are involved in regulation of chylomicron remodeling?
Key genes include CD36, LPL, APOA4, APOB, APOC2, APOE, MEN1, and lymphatic regulators such as VEGFR3.
How do chylomicrons affect intestinal lipid absorption?
Chylomicrons regulate lacteal permeability and intestinal lipid absorption, influencing how dietary fats are transported.
What is the role of CD36 in chylomicron remodeling?
Intestinal CD36 is a key protein of lipid utilization involved in fatty acid uptake and gut homeostasis.
Can CRISPR be used to study chylomicron remodeling?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate regulators.
What diseases are linked to chylomicron remodeling?
Dysregulation is linked to hypertriglyceridemia and metabolic disorders influenced by genetics and lifestyle.
How is lipoprotein lipase involved in chylomicron remodeling?
Lipoprotein lipase hydrolyzes triglyceride within chylomicrons, releasing free fatty acids as part of the remodeling process.
What models are used to study chylomicron remodeling?
Models include intestinal knockout mice, lymphatic imaging, dietary modification studies, and liver cell co-culture.
Why is regulation of chylomicron remodeling important for metabolic health?
It controls lipid absorption and clearance, and its dysregulation contributes to hypertriglyceridemia and metabolic disease.
Conclusion
GO:0090318 regulation of chylomicron remodeling defines a critical biological process that controls how dietary lipids are packaged, modified, and cleared. Chylomicrons regulate lacteal permeability and intestinal lipid absorption, and key proteins such as CD36 and lipoprotein lipase are central to this regulation. Dysregulation is linked to hypertriglyceridemia and metabolic disease, with genetic and lifestyle factors shaping risk. CRISPR-based models offer powerful tools to test causal roles of candidate genes and advance therapeutic development.
References
- 1. Zarkada G et al.. 2023. Chylomicrons Regulate Lacteal Permeability and Intestinal Lipid Absorption.. Circ Res 133(4):333-349 PMID: 37462027
- 2. Rendina-Ruedy E et al.. 2022. Common Dietary Modifications in Preclinical Models to Study Skeletal Health.. Front Endocrinol (Lausanne) 13:932343 PMID: 35909523
- 3. Hur HJ et al.. 2025. Integrating genetics and lifestyles for precision nutrition in hypertriglyceridemia: A UK Biobank and KoGES analysis.. J Clin Lipidol 19(4):942-959 PMID: 40517091
- 5. Cifarelli V et al.. 2018. Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis.. Compr Physiol 8(2):493-507 PMID: 29687890
- 6. Cao X et al.. 2026. Inhibiting menin attenuates high-fat diet-induced weight gain by limiting intestinal lipid absorption in mice.. J Clin Invest PMID: 42579365
- 7. Kmieć Z. 2001. Cooperation of liver cells in health and disease.. Adv Anat Embryol Cell Biol 161:III-XIII, 1-151 PMID: 11729749
- 8. Gracia G et al.. 2020. Organ-specific lymphatics play distinct roles in regulating HDL trafficking and composition.. Am J Physiol Gastrointest Liver Physiol 318(4):G725-G735 PMID: 32068443
